National and state vaccination coverage among adolescents aged 13 through 17 years--United States, 2010.
National and state vaccination coverage among adolescents aged 13 through 17 years--United States, 2010.
复制标题
13 至 17 岁青少年的国家和州疫苗接种覆盖率——美国，2010 年。
DOI：
--
复制
发表时间：
2011
期刊：
影响因子：
--
通讯作者：
T. Hernandez
中科院分区：
文献类型：
--
作者：
A. D. Hond;Vaibhavi Shah;Ilse M. J. Kant;B. Calster;E. Steyerberg;T. Hernandez
免疫实践咨询委员会 (ACIP) 建议青少年定期接受脑膜炎球菌结合物（MenACWY，2 剂）；破伤风、白喉、无细胞百日咳（Tdap，1剂）；和人乳头瘤病毒（HPV，3 剂）疫苗（建议所有 6 个月及以上的人每年接种流感疫苗）。 CDC 通过国家青少年免疫调查 (NIS-Teen) 跟踪 13 至 17 岁青少年的疫苗接种覆盖率。为了提供更新的疫苗接种覆盖率估计值，CDC 分析了 2010 年 NIS-Teen 数据，并将结果与 2009 年 NIS-Teen 估计值进行了比较。本报告总结了该分析的结果，发现所有三种常规接种的青少年疫苗的覆盖率均有所增加：Tdap 从 55.6% 增加到 68.7%，MenACWY 从 53.6% 增加到 62.7%，（女性中）≥1 剂 HPV 从 44.3% 增加到 48.7%，≥3 剂 HPV 从 26.7% 增加到 32.0%。各州的疫苗接种覆盖率差异很大；三个州（马萨诸塞州、罗德岛州和华盛顿州）对于所有三种疫苗（Tdap、MenACWY 和 HPV）≥1 剂的覆盖率均超过 65%。需要继续评估疫苗接种促进举措，包括国家疫苗接种融资政策，以了解其对青少年疫苗接种的影响并促进有效的做法。
The Advisory Committee on Immunization Practices (ACIP) recommends that adolescents routinely receive meningococcal conjugate (MenACWY, 2 doses); tetanus, diphtheria, acellular pertussis (Tdap, 1 dose); and human papillomavirus (HPV, 3 doses) vaccines (influenza vaccine is recommended annually for all persons aged 6 months and older). CDC tracks vaccination coverage among adolescents aged 13 through 17 years through the National Immunization Survey--Teen (NIS-Teen). To provide updated vaccination coverage estimates, CDC analyzed 2010 NIS-Teen data and compared results with 2009 NIS-Teen estimates. This report summarizes the results of that analysis, which found that coverage increased for all three of the routinely administered adolescent vaccines: Tdap from 55.6% to 68.7%, MenACWY from 53.6% to 62.7%, (among females) ≥1 dose of HPV from 44.3% to 48.7%, and ≥3 doses of HPV from 26.7% to 32.0%. Vaccination coverage varied widely among states; three states (Massachusetts, Rhode Island, and Washington) had coverage of >65% for ≥1 dose of all three vaccines (Tdap, MenACWY, and HPV). Continued evaluation of vaccination-promoting initiatives, including state vaccination-financing policies, is needed to understand their impact on adolescent vaccination and to promote effective practices.